Literature DB >> 11175170

Three-Dimensional Echocardiography: The Gateway to Virtual Reality!

Nico Bruining1, Jos R. T. C. Roelandt, Gernoth Grunst, Thomas Berlage, Johannes Waldinger, Bernhard Mumm.   

Abstract

Virtual reality (VR) is one of the latest developments in cardiac three-dimensional (3-D) ultrasound. A VR heart model linked to 3-D echocardiographic image datasets provides the observers spatial information regarding a 3-D image dataset and prevents the "lost in space effect" in difficult and relevant coupled diseases when integrated into 3-D reconstruction software. Standardized echocardiographic views can be selected within the integrated developed VR heart model, and this is the first step to automatic 3-D computations with minimal operator interaction. VR heart models open exciting opportunities in the field of teaching echocardiographic cardiology, diagnosis, and examinable states.

Year:  1999        PMID: 11175170     DOI: 10.1111/j.1540-8175.1999.tb00085.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  Three-dimensional echocardiographic virtual endoscopy for the diagnosis of congenital heart disease in children.

Authors:  Haihong Xue; Kun Sun; Jianguo Yu; Binjin Chen; Guozhen Chen; Wenjing Hong; Liping Yao; Lanping Wu
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-10       Impact factor: 2.357

2.  Dynamic 3D echocardiography in virtual reality.

Authors:  Annemien E van den Bosch; Anton H J Koning; Folkert J Meijboom; Jackie S McGhie; Maarten L Simoons; Peter J van der Spek; Ad J J C Bogers
Journal:  Cardiovasc Ultrasound       Date:  2005-12-23       Impact factor: 2.062

3.  Virtual reality 3D echocardiography in the assessment of tricuspid valve function after surgical closure of ventricular septal defect.

Authors:  Goris Bol Raap; Anton H J Koning; Thierry V Scohy; A Derk-Jan ten Harkel; Folkert J Meijboom; A Pieter Kappetein; Peter J van der Spek; Ad J J C Bogers
Journal:  Cardiovasc Ultrasound       Date:  2007-02-16       Impact factor: 2.062

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.